| Ytd | -22.29% | |
| 1y | -57.91% |
| Open | 0.58 | Prev Close | 0.58 | Low | 0.59 | High | 0.61 | Mkt Cap | 2.73M |
| Vol | 66.36K | Avg Vol | 53.63K | EPS | -4.95 | P/E | N/A | Forward P/E | -0.03 |
| Beta | 0.48 | Short Ratio | 0.43 | Inst. Own | 11.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.60 | 200-d Avg | 0.86 | 1yr Est | 90.00 |
OGEN News
Oragenics (AMEX:OGEN) reported quarterly losses of $(0.51) per share. This is a 85.83 percent increa
The Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strateg
• Enrollment underway at Mackay Base Hospital in Queensland, Australia; additional sites in final ac
Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed with
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targe
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targe
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targe
Oragenics, Inc. (NYSE:OGEN) ("the "Company") a clinical-stage biotechnology company deve
Oragenics, Inc. (NYSE American: OGEN) ("the "Company"), a clinical-stage biotechnology c
Oragenics (AMEX:OGEN) reported quarterly losses of $(1.96) per share. This is a 82.69 percent increa
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targe
Oragenics, Inc. (NYSE:OGEN), a clinical-stage biotechnology company pioneering intranasal drug deliv
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company
On Monday, 89 stocks made new 52-week lows.
On Friday, 469 companies hit new 52-week lows.
On Thursday, 175 stocks hit new 52-week lows.
On Wednesday, 479 stocks made new 52-week lows.
On Wednesday, 116 companies set new 52-week lows.
On Tuesday, 72 companies hit new 52-week lows.
On Wednesday, 258 companies hit new 52-week lows.
On Wednesday, 152 stocks made new 52-week lows.
On Wednesday, 283 companies set new 52-week lows.
Friday's session saw 236 companies set new 52-week lows.
On Tuesday, 120 companies set new 52-week lows.
On Friday morning, 446 companies hit new 52-week lows.
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings fo
During Tuesday's trading, 505 companies set new 52-week lows.
Gainers XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) shares rose 152.6% to $7.30 in pre-market trad
Stocks Which Set New 52-Week Lows Friday, August 3rd
Stocks Which Set New 52-Week Low Yesterday, August 2nd